3 not yet recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 3 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Endometriosis (Diagnosis): new trials by email Literature Review of Endometriosis (Diagnosis) trials Research Report on Endometriosis (Diagnosis)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis Desloratadine, Placebo - Endometriosis, Endometriosis (Diagnosis) | Phase 2 | Not yet recruiting | Medical University of Vienna | 60 | 2027-02-01 | 2026-09-18 |
| PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates Teverelix DP, Teverelix DP Placebo - Endometriosis Pelvic, Endometriosis Ovaries | Phase 2 | Not yet recruiting | Antev Ltd. | 84 | 2027-02-01 | 2026-11-03 |
| FAPI PET Imaging - An Exploratory Study [18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N) | Phase 1 / Phase 2 | Not yet recruiting | Martin Huellner | 770 | 2026-08-01 | 2026-07-15 |
Disease (3) · Endometriosis (3) · Dysmenorrhea (2) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Transitional Cell (1) · Dyspareunia (1) · Head and Neck Neoplasms (1) · Infertility (1) · Liver Cirrhosis (1) · Mesothelioma (1) · Multiple Myeloma (1) · Pancreatic cancer, adult (1) · Plasmacytoma (1) · Prostatic Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Urogenital Diseases (3) · Genital Diseases, Male (2) · Male Urogenital Diseases (2) · Menstruation Disturbances (2) · Neurologic Manifestations (2) · Pain (2) · Pelvic Pain (2) · Signs and Symptoms (2) · Adenocarcinoma (1)
desloratadine (1)
Antev Ltd. (1) · Martin Huellner (1) · Medical University of Vienna (1)
Austria (1) · Switzerland (1)